Welcome to our dedicated page for Fuller H B Co SEC filings (Ticker: FUL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The H.B. Fuller Company (NYSE: FUL) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret them. H.B. Fuller is a Minnesota-based issuer that describes itself as the largest pureplay adhesives company in the world, focused on adhesives, sealants, functional coatings and other chemical-based products.
Investors can use this page to access current and historical Forms 8‑K, which H.B. Fuller files to report material events such as quarterly and annual earnings releases, dividend declarations and board changes. Recent 8‑K filings referenced in the input include items under Item 2.02 – Results of Operations and Financial Condition and Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers, along with exhibits that attach the related press releases.
In addition to event-driven reports, users can review the company’s annual reports on Form 10‑K and quarterly reports on Form 10‑Q (when available in the feed). These filings typically provide detailed information on net revenue, margins, net income, cash flow, segment performance, risk factors and other disclosures that complement the non‑GAAP metrics discussed in earnings releases and Regulation G reconciliation tables.
Stock Titan’s platform enhances these documents with AI-powered summaries that explain key sections of lengthy filings, highlight important changes from prior periods and clarify technical language. Real-time updates from EDGAR ensure that new H.B. Fuller filings appear promptly, while links to exhibits make it easier to connect narrative disclosures with supporting press releases and financial tables.
For users researching FUL, this page offers a focused view of H.B. Fuller’s regulatory history, from material event 8‑Ks to periodic reports, helping readers understand how the adhesives manufacturer describes its operations, financial condition, governance and risk profile in formal SEC documents.
Director Teresa J. Rasmussen Trangsrud of FULLER H B CO received a grant of 1,000 shares of Common Stock at $65.83 per share as equity compensation. Following this grant, she directly owns 3,391.433 shares of common stock.
She also holds 20,839.95 stock units that each convert into one share of common stock. According to the plan terms, these stock units are generally converted into common shares upon retirement, death, disability, or other specified events, and some units were accumulated through a dividend reinvestment plan and dividend equivalent features.
H.B. Fuller Company reported the results of its 2026 Annual Meeting of Shareholders. Shareholders elected three directors to three‑year terms, with support ranging from about 47.6 million to 49.7 million votes, with broker non‑votes reported in each case.
They also ratified Ernst & Young LLP as independent auditor for the fiscal year ending November 28, 2026, with 51,490,426 votes for, 286,686 against, and 13,849 abstentions. In a non‑binding advisory vote, shareholders approved the compensation of named executive officers with 48,718,166 votes for, 1,227,485 against, 122,041 abstentions, and 1,723,269 broker non‑votes. A quorum was present, with 51,790,961 of 54,475,433 eligible common shares represented.
FULLER H B CO Executive VP and CFO John J. Corkrean received a grant of 197.760 Phantom Units on Common Stock, treated as a derivative award. The grant is priced at $63.73 per unit and increases his Phantom Unit balance to 33,255.040 units, which convert into common stock on a 1-for-1 basis under the Key Employee Deferred Compensation Plan.
The filing also lists existing holdings, including multiple Employee Stock Option awards and Restricted Stock Units that vest in annual installments and convert into common stock on a 1-for-1 basis. The report shows no open‑market purchases or sales, only this compensation-related acquisition and updated derivative and stock holdings.
H.B. Fuller senior vice president Heather Campe received a grant of 34.96 phantom units on common stock, recorded at $63.73 per unit. These units convert into common shares on a 1-for-1 basis under the Key Employee Deferred Compensation Plan, bringing her phantom unit balance to 5,533.25 units. The filing also lists existing employee stock options on common stock with exercise prices between $51.89 and $77.72 per share, multiple restricted stock unit awards that convert 1-for-1 into common shares, and a direct holding of 24,653.0782 common shares.
H.B. Fuller President and CEO Celeste Beeks reported an open-market purchase of 5,170 shares of common stock at $57.08 per share through a revocable trust, bringing that indirect holding to 8,670 shares as of the transaction date.
In addition to these shares, she holds a sizable package of employee stock options and restricted stock units that can convert into common stock over time, including option grants exercisable at prices between $59.81 and $77.72 per share and multiple RSU awards that settle on a 1-for-1 share basis.
FULLER H B CO executive Heather Campe, Senior Vice President of International Growth, received a compensation-related grant of 37.65 Phantom Units on March 27, 2026 at a reference value of $59.17 per unit. After this award, she holds 5,498.29 Phantom Units, which convert into common stock on a 1-for-1 basis under the company’s deferred compensation plan. The filing also lists substantial existing equity incentives, including multiple employee stock options on tens of thousands of shares at exercise prices between the low-$50s and high-$70s, several blocks of restricted stock units that vest in annual installments, and 24,653.0782 shares of common stock held directly, some accumulated through dividend reinvestment and dividend equivalent features.
H.B. Fuller’s Executive VP and CFO John J. Corkrean received a grant of 213 Phantom Units on March 27, 2026, at a reference price of $59.17 per unit. These units convert into common stock on a 1-for-1 basis under the company’s deferred compensation plan.
After this award, Corkrean holds a total of 33,057.28 Phantom Units, along with 59,508 shares of common stock held directly. He also retains multiple employee stock option grants on common stock with exercise prices ranging from $45.05 to $77.72 and expiration dates running through 2036, plus several tranches of restricted stock units that likewise convert 1-for-1 into common shares as they vest.
The Vanguard Group files Amendment No. 15 reporting zero beneficial ownership of HB Fuller Co. common stock. The filing states amount beneficially owned: 0 and percent of class: 0%. It explains an internal realignment that disaggregated certain Vanguard subsidiaries' reporting, per SEC Release No. 34-39538.
The form lists Vanguard's address and confirms no sole or shared voting or dispositive power over HB Fuller shares. The filing is signed by Vanguard's Head of Global Fund Administration.
H.B. Fuller reported first-quarter 2026 net revenue of $770.8 million, down 2.3% from a year earlier, as lower volumes more than offset modest price gains. Gross margin improved to 30.6% from 28.8% thanks to higher pricing, lower raw material costs and contributions from recent acquisitions.
Net income attributable to H.B. Fuller rose to $21.0 million, or $0.38 per diluted share, compared with $13.2 million, or $0.24, a year ago. Adjusted EBITDA increased to $118.7 million, a 15.4% margin, up from 14.5%.
Hygiene, Health and Consumable Adhesives revenue declined, while Engineering Adhesives grew and Building Adhesive Solutions was essentially flat. Cash flow from operations was a small outflow of $4.0 million, significantly better than the prior-year outflow. Long-term debt was $2.08 billion, with a debt-to-total-capital ratio of 50.1%.
H.B. Fuller reported mixed first-quarter 2026 results with stronger profitability despite lower sales. Net revenue was $770.8 million, down 2.3% year-on-year as volumes declined, leading to a 6.6% organic revenue drop, partly offset by better pricing, foreign exchange and acquisitions.
Net income attributable to H.B. Fuller rose to $21.0 million from $13.2 million, and diluted EPS increased to $0.38. Adjusted net income was $31.5 million, with adjusted diluted EPS of $0.57, up 6%. Adjusted EBITDA reached $118.7 million, up 4%, and adjusted EBITDA margin improved to 15.4%, a gain of 90 basis points driven by pricing, lower raw material costs, cost savings initiatives and acquisitions.
By segment, Engineering Adhesives and Hygiene, Health and Consumable Adhesives both expanded adjusted EBITDA and margins, while Building Adhesive Solutions held margins steady. Net debt was $1.97 billion with net debt-to-adjusted EBITDA at 3.1x, improved from 3.5x a year earlier. Operating cash flow improved by $49 million year-on-year, though it remained a small use of cash in the quarter. Based on year-to-date performance and macro conditions, the company increased its full-year 2026 revenue, adjusted EBITDA and adjusted EPS guidance.